Diseases, Conditions, Syndromes

WHO approves new, faster treatment for drug-resistant TB

The World Health Organization approved a new treatment for multi-drug resistant tuberculosis (MDR-TB) on Thursday, a crucial step towards replacing an old, costly therapy that is brutal on patients and only 50-percent effective.

Oncology & Cancer

Safety, efficacy of at-home laser for periobital wrinkles studied

(HealthDay)—A handheld nonablative fractional laser is safe and seems effective for home use for treating periorbital wrinkles, according to a study published in the November issue of the Journal of the American Academy ...

Oncology & Cancer

Prolonged dexamethasone cuts delayed nausea after chemo

(HealthDay) -- Adding dexamethasone to prochlorperazine on days two and three, following palonosetron and dexamethasone on day one, reduces delayed nausea (DN) in patients receiving chemotherapy containing a platinum-based ...

Diseases, Conditions, Syndromes

Trial for new drug-resistant TB treatment to begin

A global health alliance Monday unveiled plans for the first clinical tests of a new treatment regimen for tuberculosis, including for patients with resistance to existing multidrug programs.

page 8 from 16